tirzepatide injection new market cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says Lilly launches lower-price weight-loss drug

Coverage and accessibility is definitely going to be the biggest challenge as we move forward in treating people with obesity. Benefits beyond weight loss In August, Novo Nordisk, the maker of Ozempic and Wegovy, became the first to demonstrate in a large clinical trial that the drugs provide health benefits beyond weight loss and diabetes management

Keep an eye on your lab results, too

Its about increasing treatment options and personalizing it to each patients preferences and needs, the researchers wrote

Food and protein Track nutrition for low-appetite days GLP-1 medication can change hunger, meal size, and food tolerance